PNC Infratech Ltd.: Q3FY18 Result Update

Similar documents
Dilip Buildcon Ltd.: Q3FY18 Result Update

Jindal Stainless Hisar Ltd.: Q3FY18 Result Update

Ujjivan Financial Services Ltd.: Q3FY18 Result Update

Trident Ltd: Q2FY18 Result Update

Trident Ltd.: Q1FY18 Result Update

Transformer and Rectifier (India) Ltd: Q4FY17 Result Update

Economic Spotlight. Current Account Deficit Narrows. Edelweiss Investment Research

RELIANCE INDUSTRIES LIMITED

Economic Spotlight. Revised Govt. Borrowing Means More Fiscal Room. Edelweiss Investment Research

Zee Learn Ltd.: Q2FY18 Result Update

Ratnamani Metals & Tubes Ltd.: Q1FY18 Results Update

JSW Steel EDELSTAR FUNDAMENTAL RESEARCH

Kirloskar Brothers Ltd.: Q1FY18 Result Update

Emami Ltd. EDELSTAR FUNDAMENTAL RESEARCH

First Flash: Butterfly Gandhimathi Appliances Ltd

Performance Tracker Equity

Kirloskar Brothers Ltd.: Q4FY17 Result Update

S P Apparels Ltd.: Q2FY18 Result Update

S.P.Apparels Ltd. Q1FY18 Result Update

Edelweiss Investment Research Stock view: Axis Bank Ltd. Axis Bank Ltd.

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

Amber Enterprises India Ltd

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

Cummins India Ltd Bloomberg Code: KKC IN

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

Kalpataru Power. Rating: Target price: EPS: Rating CMP. Target BUY. Rs Rs.256

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights

Adani Ports & SEZ Rating: Target price: EPS:

Visaka Industries Ltd

Fineotex Chemical Ltd

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

BUY MULTI COMMODITY EXCHANGE OF INDIA. Demonetization,GST uncertainty impact Q4. Target Price: Rs 1,397. Concall highlights

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

BUY. Robust quarter with clear growth visibility DILIP BUILDCON. Target Price: Rs 610. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E

Jamna Auto Industries

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2,

Key estimate revision. Year FY14 23,28,609 3,48,027 1,40, FY15E 25,74,029 3,94,133 1,69,

CMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7

BUY MULTI COMMODITY EXCHANGE OF INDIA. Strong Q2; All eyes on option volumes. Target Price: Rs 1,280. Concall highlights

Sanghvi Movers Ltd. Results above estimates. Figure 1: Actual Vs Religare Estimates. Financial highlights. Valuations and Recommendation

MCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176

Ramco Cement. Rating: Target price: EPS: Rating CMP. Target BUY. Rs.415. Rs. 360

Gillette India. Institutional Equities. 1QFY18 Result Update

HCL Technologies. Rating: Target price: EPS: Target CMP. Rating. Rs. 826 REDUCE. Rs.760

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

Institutional Equities

BUY. Outperformance continues GULF OIL LUBRICANTS INDIA. Target Price: Rs 1,000. Hike estimates and TP; maintain BUY

Balkrishna Industries

HINDUSTAN UNILEVER Indulekha allure for the tresses

Change EPS. (Rs) FY

Ahluwalia Contracts (India)

Colgate-Palmolive (India)

Key estimate revision. Financial summary. Year

He is BTech from IIT Bombay ( , Aeronautical Engineering) and MS from Cornell University ( , Mechanical Engineering).

Indian Oil Corporation

Simplex Infrastructures

Dr Reddy s Laboratories

ITC. Rating: Target price: EPS: Relative better visibility despite the smoke, Maintain BUY CMP. Target. Rating. Rs.389. Buy. Rs.

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

Key estimate revision. Financial summary. Year FY15 121, % 16, % FY16E 137, % 20,

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

Indo Count Industries BUY

HOLD. Performance remains weak COLGATE-PALMOLIVE INDIA. Target Price: Rs 900

Near-term pressure, but long-term outlook positive

Initiating Coverage. Uflex Ltd.

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

ITC Ltd. RESULT UPDATE 27th October, 2017

Techno Electric & Engineering Limited

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Hold Target Price: Rs 574

Colgate-Palmolive India Ltd.

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

Wipro. 4QFY18 Result Update. Still not of the woods, maintain Hold. Sector: Technology CMP: ` 287. Recommendation: Hold

Mahindra & Mahindra Ltd.

CMP* (Rs) 840 Upside/ (Downside) (%) (2.4) Bloomberg Ticker Market Cap. (Rs bn) 379 Free Float (%) 53 Shares O/S (mn) 451.6

Result Update. Sterling Tools. Buy

CMP* (Rs) 242 Upside/ (Downside) (%) 2. Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630

Nestlé India Outlook Hazy; Valuations Prohibitive

Key estimate revision. Year CY14 87,383 11,148 6, CY15E 1,20,126 17,838 9,

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,226 Target Price `3,466. 3QFY2017 Result Update Automobile. 3-year price chart

TVS Motors. Source: Company Data; PL Research

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

Hindustan Unilever (RHS)

HOLD PVR. Operating matrix healthy; footfalls subdued. Target Price: Rs 1,520. Key highlights

Titan Company BUY. Back to Value Zone Validate Rating Upgrade. Institutional Equity Research. November 05, Target Price Rs428.

Robust results, TLT margins improved profitability.

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Symphony Ltd. RESULT UPDATE 31st October 2017

MCX Ltd. Rating: Target price: EPS: Is commodity option a game changer for MCX? - Unlikely. Target. Rating CMP. Rs. 1,080 SELL. Rs.

Britannia Industries

NOW ON APP Research at your finger tips

BUY. Strong quarter, bright outlook MAHINDRA CIE AUTOMOTIVE. Target Price: Rs 274. Takeaways from concall. Key drivers (%)

Dalmia Bharat Enterprises

Asian Paints. Source: Company Data; PL Research

Transcription:

Edelweiss Investment Research PNC Infratech Ltd.: Q3FY18 Result Update Execution pickup to drive growth PNC Infratech (PNC), one of the largest EPC road constructors in India with more than INR 10,000 cr of order book reported its Q3FY18 results. After five quarters of consistent de-growth, topline reported 2% YoY growth backed by beginning of execution in certain large projects. The company reported EBITDA margins of 14%, a 100 bps improvement YoY and was higher than our expectations. PNC, after reporting de-growth in FY17 and muted performance in FY18E, is expected to report strong recovery in FY19E onwards as more than ~INR 10,000 cr orderbook offers higher revenue visibility and beginning of execution is expected to drive the revenue growth going forward. With the growth coming back, we expect the RoCE to improve significantly in FY19E onwards. We believe, RoCE to reach 16% in FY20E against 12% in FY17. We believe, PNC will out-beat consensus estimates both topline and bottom-line levels in FY19E. Our FY19E estimates are 8% higher at the revenue levels and 12% higher at PAT levels. we reiterate our BUY recommendation on the stock with a revised target price of INR 240. Strong Order-book and receding execution challenges to drive revenue growth going forward PNC reported INR 7,976 cr of order book at the end of Q3FY18, and with the wining of new HAM project worth INR 2,159 cr, order book currently stands at INR 10,135 cr which offers more than 6 years of revenue visibility. Revenue performance of the company got impacted over the last five quarters, as orders worth ~INR 3,000 cr got delayed or stuck due to land acquisition issues. However, the situation has improved in the recent past and we believe, the company is expected to experience strong growth momentum from Q4FY18 onwards. Revenue to grow at 30% CAGR over FY17-20E, Margin to maintain upward trajectory With the execution beginning in large HAM projects, strong rebound in revenue is expected in FY19E onwards and we believe the topline of PNC to grow at 30% CAGR over FY17-20E to reach INR 3,595 cr in FY20E. Managment is confident of growing revenue by 10% in FY18E and 40-50% in FY19E. We beleive, topline growth in FY18E would be 6-7%, but in FY19E revenue is expected to grow by whopping 60-65% YoY. PNC is also expected to maintan EBITDA margin in the range of 13.5 14%. CMP INR: 173 Rating: BUY Target Price INR: 240 Upside: 28% Debashish Mazumdar Research Analyst debashish.mazumdar@edelweissfin.com Bloomberg: 52-week range (INR): Share in issue (cr): PNCL:IN 228.30 / 99.50 25.7 M cap (INR cr): 4,433 Avg. Daily Vol. BSE/NSE :( 000): Promoter Holding (%) 200 56.07 Our FY19E Revenue/PAT estimates are 8/12% Higher than consensus estimates; Reiterate BUY We believe, PNC will out-beat consensus estimates both at topline and bottom-line levels in FY19E. Our FY19E estimates are 8% higher at the revenue levels and 12% higher at PAT levels. we reiterate our BUY recommendation on the stock with a target price of INR 240. We value its standalone EPC business at INR 201 / share (at 18x FY20E P/E) & BOT projects at INR 39 / share. Year to March (INR cr) Q3FY18 Q3FY17 YoY (%) Q1FY18 QoQ (%) FY17 FY18E FY19E Net Revenue 472 464 1.9% 269 76% 1,689 1,812 2,986 Revenue Growth(%) -16.1% 7.3% 64.8% EBITDA 66 60 10.1% 40 67% 221 236 403 EBITDAM (%) 14.0% 13.0% 14.8% 13.1% 13.0% 13.5% Adj. PAT 93 77 21.2% 17 459% 210 141 246 Growth(%) -13.6% -32.9% 75.1% Adj. Diluted EPS (INR) 3.6 3.0 21.2% 0.6 459% 8.2 5.5 9.6 Diluted P/E (x) 21.8 32.4 18.5 EV/EBITDA (x) 21.5 12.8 9.6 RoCE (%) 12.4 9.3 14.4 Date: 16 th February 2018 1 GWM

Q3FY18 Result Highlights (INR Cr) Q3FY18 Q3FY17 YoY (%) Q1FY18 QoQ (%) 9MFY18 9MFY17 YoY (%) Net Revenues 472 464 2% 269 76% 1,098 1,339-18% Operating Expenses 406 403 1% 229 77% 940 1,165-19% EBITDA 66 60 10% 40 67% 158 174-9% Depreciation 20 14 42% 18 6% 56 39 41% EBIT 47 46 1% 21 120% 102 134-24% Interest expenses 7 4 65% 8-15% 22 12 86% Other income 6 8-33% 5 9% 16 36-54% PBT 46 51-10% 19 144% 97 158-39% Tax -47-26 83% 2-2319% -43-18 143% Reported PAT 93 77 21% 17 459% 140 176-21% EoI 0 0 NA 0 0 0 NA Adj PAT after EoI 93 77 21% 17 459% 140 176-21% Equity Capital 51 51-51 - 51 51 - No of Shares 25.7 25.7-25.7-5.1 5.1 - EPS 3.6 3.0-0.6-27.2 34.3 - EBITDA Margin 14.0% 13.0% - 14.8% - 14.4% 13.0% - PAT Margin 19.7% 16.6% - 6.2% - 12.7% 13.1% - Tax Rate -102.9% -50.7% - 11.3% - -44.4% -11.2% - After a huge delay, Nagina-Kashipur (TPC INR 1,156 cr) and Koliwar- Bhojpur (TPC INR 454 cr) started delivering and expected to contribute strongly going forward. Furthermore management is expected to start work on Bhojpur - Buxar (TPC INR 477 cr) in Q4FY18. In Karnataka HAM project, the company appointed date in December, 2017and the project is expected to pick up pace in the fourth quarter. Appointed date for Jhansi-Khajurao two packages is expected to come by the end of FY18 and both of them are expected to contribute significantly to the topline in FY19E The company is expected to put INR 600 cr over the period in next three years in four HAM projects. After investing INR 180 cr in FY17, the company is expected to invest further INR 120 cr in FY18E and already invested around INR 60 cr in first nine months. Due to high receivable days, overall working capital cycle of the company got extended to 143 days in against 123 days in the previous quarter. Due to low revenue growth, high capex and higher investment in BOT projects, debt of the company is expected to move upwards to INR 200 cr against INR 140 cr last year and INR 11 cr in FY16. 2 GWM

Financials Income statement (INR cr) Income from operations 2,014 1,689 1,812 2,986 3,835 Construction Cost 1,468 1,187 1,277 2,090 2,684 Employee costs 84 100 118 194 230 Other expenses 196 181 181 299 383 Total operating expenses 1,748 1,468 1,576 2,583 3,298 EBITDA 266 221 236 403 537 Depreciation and amortisation 52 53 70 86 95 EBIT 213 168 166 318 442 Interest expenses 33 20 38 62 74 Other income 20 47 28 34 40 Profit before tax 200 194 156 290 408 Provision for tax -42-16 16 43 122 Reported profit 243 210 141 246 286 Extraordinary items 0 0 0 0 0 Profit after tax 243 210 141 246 286 Minority interest 0 0 0 0 0 Share from associates 0 0 0 0 0 Adjusted net profit 243 210 141 246 286 Equity shares outstanding (mn) 25.7 25.7 25.7 25.7 25.7 EPS (INR) basic 9.5 8.2 5.5 9.6 11.1 Diluted shares (mn) 25.7 25.7 25.7 25.7 25.7 EPS (INR) fully diluted 9.5 8.2 5.5 9.6 11.1 Dividend per share 0.25 0.00 0.00 0.00 0.00 Dividend payout (%) 0.0 0.0 0.0 0.0 0.0 Common size metrics - as % of net revenues Operating expenses 86.8 86.9 87.0 86.5 86.0 Depreciation 2.6 3.2 3.8 2.9 2.5 Interest expenditure 1.6 1.2 2.1 2.1 1.9 EBITDA margins 13.2 13.1 13.0 13.5 14.0 Net profit margins 12.1 12.4 7.8 8.3 7.5 Growth metrics (%) Revenues 29.0 (16.1) 7.3 64.8 28.4 EBITDA 61.2 (16.9) 6.6 71.1 33.2 PBT 108.4 (3.2) (19.4) 85.4 40.8 Net profit 393.7 (13.6) (32.9) 75.1 15.9 EPS 393.7 (13.6) (32.9) 75.1 15.9 Ratios ROAE (%) 12% 12% 8% 8% 7% ROACE (%) 16% 12% 9% 14% 17% Debtors (days) 68.2 136.3 121.7 91.3 91.3 Current ratio 2.8 2.3 2.4 2.0 1.9 Debt/Equity 0.1 0.2 0.3 0.4 0.3 Inventory (days) 42.8 33.2 51.7 43.8 38.3 Payable (days) 17.1 51.2 46.8 46.2 46.2 Cash conversion cycle (days) 94.0 118.3 126.6 88.9 83.4 Debt/EBITDA 0.0 0.8 1.6 1.3 1.1 Adjusted debt/equity 0.0 0.1 0.2 0.3 0.3 Balance sheet (INR cr) As on 31st March FY16 FY17 FY18 FY19 FY20 Equity share capital 51 51 51 51 51 Equity Warrant 0 0 0 0 0 Reserves & surplus 1,327 1,521 1,660 1,907 2,193 Shareholders funds 1,378 1,572 1,712 1,958 2,244 Secured loans 6 112 0 0 0 Unsecured loans 6 58 537 687 737 Borrowings 12 169 537 687 737 Deffered tax liability 0 0 0 0 0 Sources of funds 1,390 1,741 2,248 2,645 2,981 Gross block 431 602 775 950 1,050 Depreciation 219 255 325 410 505 Net block 212 347 450 540 545 Capital work in progress 2 8 18 28 38 Total fixed assets 214 355 468 568 583 Non Current Assets 707 900 1,100 1,350 1,550 Inventories 236 153 257 358 403 Sundry debtors 376 631 604 747 959 Cash and equivalents 97 35 35 84 155 Loans and advances 125 173 273 273 273 Other current assets 0 0 0 0 0 Total current assets 835 993 1,169 1,461 1,789 Sundry creditors and others 270 372 488 733 941 Provisions 20 21 0 0 0 Total CL & provisions 290 392 488 733 941 Net current assets 544 600 681 728 848 Net deferred tax 0 0 0 0 0 Misc expenditure 0 0 0 0 0 Uses of funds 1,465 1,855 2,249 2,645 2,981 Cash flow statement Net profit 243 210 141 246 286 Add: Depreciation 52 53 70 86 95 Add: Misc expenses written off 0 0 0 0 0 Add: Deferred tax 0 0 0 0 0 Add: Others 0 0 0 0 0 Gross cash flow 295 263 211 332 380 Less: Changes in W. C. -28 87 28-2 49 Operating cash flow 324 176 183 334 331 Less: Capex 49 171 175 175 100 Less: Invstment in Subsidiaries 35 121 200 250 200 Free cash flow 274 5 8 159 231 Valuation parameters Diluted EPS (INR) 9.5 8.2 5.5 9.6 11.1 Y-o-Y growth (%) 393.7 (13.6) (32.9) 75.1 15.9 CEPS (INR) 11.5 10.3 8.2 12.9 14.8 Diluted P/E (x) 18.8 21.8 32.4 18.5 16.0 Price/BV(x) 3.3 2.9 2.7 2.3 2.0 EV/Sales (x) 2.3 2.9 2.8 1.7 1.3 EV/EBITDA (x) 17.4 22.0 21.5 12.8 9.6 Diluted shares O/S 25.7 25.7 25.7 25.7 25.7 Basic EPS 9.5 8.2 5.5 9.6 11.1 Basic PE (x) 18.8 21.8 32.4 18.5 16.0 Dividend yield (%) 0.0 0.0 0.0 0.0 0.0 3 GWM

Jan-16 Feb-16 Mar-16 Apr-16 May-16 Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 (Indexed) Edelweiss Broking Limited, 1st Floor, Tower 3, Wing B, Kohinoor City Mall, Kohinoor City, Kirol Road, Kurla(W) Board: (91-22) 4272 2200 Vinay Khattar Head Research vinay.khattar@edelweissfin.com Rating Buy Hold Reduce Expected to appreciate more than 15% over a 12-month period appreciate between 5-15% over a 12-month period Return below 5% over a 12-month period 240 220 200 180 160 140 120 100 80 PNC Sensex 4 GWM

Disclaimer Edelweiss Broking Limited ( EBL or Research Entity ) is regulated by the Securities and Exchange Board of India ( SEBI ) and is licensed to carry on the business of broking, depository services and related activities. The business of EBL and its Associates (list available on www.edelweissfin.com) are organized around five broad business groups Credit including Housing and SME Finance, Commodities, Financial Markets, Asset Management and Life Insurance. Broking services offered by Edelweiss Broking Limited under SEBI Registration No.: INZ000005231; Name of the Compliance Officer: Mr. Brijmohan Bohra, Email ID: complianceofficer.ebl@edelweissfin.com Corporate Office: Edelweiss House, Off CST Road, Kalina, Mumbai - 400098; Tel. 18001023335/022-42722200/022-40094279 This Report has been prepared by Edelweiss Broking Limited in the capacity of a Research Analyst having SEBI Registration No.INH000000172 and distributed as per SEBI (Research Analysts) Regulations 2014. This report does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. The information contained herein is from publicly available data or other sources believed to be reliable. This report is provided for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult his own advisors to determine the merits and risks of such investment. The investment discussed or views expressed may not be suitable for all investors. This information is strictly confidential and is being furnished to you solely for your information. This information should not be reproduced or redistributed or passed on directly or indirectly in any form to any other person or published, copied, in whole or in part, for any purpose. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject EBL and associates / group companies to any registration or licensing requirements within such jurisdiction. The distribution of this report in certain jurisdictions may be restricted by law, and persons in whose possession this report comes, should observe, any such restrictions. The information given in this report is as of the date of this report and there can be no assurance that future results or events will be consistent with this information. This information is subject to change without any prior notice. EBL reserves the right to make modifications and alterations to this statement as may be required from time to time. EBL or any of its associates / group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. EBL is committed to providing independent and transparent recommendation to its clients. Neither EBL nor any of its associates, group companies, directors, employees, agents or representatives shall be liable for any damages whether direct, indirect, special or consequential including loss of revenue or lost profits that may arise from or in connection with the use of the information. Our proprietary trading and investment businesses may make investment decisions that are inconsistent with the recommendations expressed herein. Past performance is not necessarily a guide to future performance.the disclosures of interest statements incorporated in this report are provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. The information provided in these reports remains, unless otherwise stated, the copyright of EBL. All layout, design, original artwork, concepts and other Intellectual Properties, remains the property and copyright of EBL and may not be used in any form or for any purpose whatsoever by any party without the express written permission of the copyright holders. EBL shall not be liable for any delay or any other interruption which may occur in presenting the data due to any reason including network (Internet) reasons or snags in the system, break down of the system or any other equipment, server breakdown, maintenance shutdown, breakdown of communication services or inability of the EBL to present the data. In no event shall EBL be liable for any damages, including without limitation direct or indirect, special, incidental, or consequential damages, losses or expenses arising in connection with the data presented by the EBL through this report. We offer our research services to clients as well as our prospects. Though this report is disseminated to all the customers simultaneously, not all customers may receive this report at the same time. We will not treat recipients as customers by virtue of their receiving this report. EBL and its associates, officer, directors, and employees, research analyst (including relatives) worldwide may: (a) from time to time, have long or short positions in, and buy or sell the securities thereof, of company(ies), mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company/company(ies) discussed herein or act as advisor or lender/borrower to such company(ies) or have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report or at the time of public appearance. EBL may have proprietary long/short position in the above mentioned scrip(s) and therefore should be considered as interested. The views provided herein are general in nature and do not consider risk appetite or investment objective of any particular investor; readers are requested to take independent professional advice before investing. This should not be construed as invitation or solicitation to do business with EBL. EBL or its associates may have received compensation from the subject company in the past 12 months. EBL or its associates may have managed or co-managed public offering of securities for the subject company in the past 12 months. EBL or its associates may have received compensation for investment banking or merchant banking or brokerage services from the subject company in the past 12 months. EBL or its associates may have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past 12 months. EBL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report. Research analyst or his/her relative or EBL s associates may have financial interest in the subject company. EBL, its associates, research analyst and his/her relative may have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report or at the time of public appearance. Participants in foreign exchange transactions may incur risks arising from several factors, including the following: ( i) exchange rates can be volatile and are subject to large fluctuations; ( ii) the value of currencies may be affected by numerous market factors, including world and national economic, political and regulatory events, events in equity and debt markets and changes in interest rates; and (iii) currencies may be subject to devaluation or government imposed exchange controls which could affect the value of the currency. Investors in securities such as ADRs and Currency Derivatives, whose values are affected by the currency of an underlying security, effectively assume currency risk. Research analyst has served as an officer, director or employee of subject Company: No EBL has financial interest in the subject companies: No EBL s Associates may have actual / beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report. Research analyst or his/her relative has actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report: No EBL has actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report: No Subject company may have been client during twelve months preceding the date of distribution of the research report. There were no instances of non-compliance by EBL on any matter related to the capital markets, resulting in significant and material disciplinary action during the last three years. A graph of daily closing prices of the securities is also available at www.nseindia.com Analyst Certification: The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. Additional Disclaimer for U.S. Persons Edelweiss is not a registered broker dealer under the U.S. Securities Exchange Act of 1934, as amended (the 1934 act ) and under applicable state laws in the United States. In addition Edelweiss is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under 5 GWM

Disclaimer applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by Edelweiss, including the products and services described herein are not available to or intended for U.S. persons. This report does not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services and/or shall not be considered as an advertisement tool. "U.S. Persons" are generally defined as a natural person, residing in the United States or any entity organized or incorporated under the laws of the United States. US Citizens living abroad may also be deemed "US Persons" under certain rules. Transactions in securities discussed in this research report should be effected through Edelweiss Financial Services Inc. Additional Disclaimer for U.K. Persons The contents of this research report have not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 ("FSMA"). In the United Kingdom, this research report is being distributed only to and is directed only at (a) persons who have professional experience in matters relating to investments falling within Article 19(5) of the FSMA (Financial Promotion) Order 2005 (the Order ); (b) persons falling within Article 49(2)(a) to (d) of the Order (including high net worth companies and unincorporated associations); and (c) any other persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as relevant persons ). This research report must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this research report relates is available only to relevant persons and will be engaged in only with relevant persons. Any person who is not a relevant person should not act or rely on this research report or any of its contents. This research report must not be distributed, published, reproduced or disclosed (in whole or in part) by recipients to any other person. Additional Disclaimer for Canadian Persons Edelweiss is not a registered adviser or dealer under applicable Canadian securities laws nor has it obtained an exemption from the adviser and/or dealer registration requirements under such law. Accordingly, any brokerage and investment services provided by Edelweiss, including the products and services described herein, are not available to or intended for Canadian persons. This research report and its respective contents do not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services. Disclosures under the provisions of SEBI (Research Analysts) Regulations 2014 (Regulations) Edelweiss Broking Limited ("EBL" or "Research Entity") is regulated by the Securities and Exchange Board of India ("SEBI") and is licensed to carry on the business of broking, depository services and related activities. The business of EBL and its associates are organized around five broad business groups Credit including Housing and SME Finance, Commodities, Financial Markets, Asset Management and Life Insurance. There were no instances of non-compliance by EBL on any matter related to the capital markets, resulting in significant and material disciplinary action during the last three years. This research report has been prepared and distributed by Edelweiss Broking Limited ("Edelweiss") in the capacity of a Research Analyst as per Regulation 22(1) of SEBI (Research Analysts) Regulations 2014 having SEBI Registration No.INH000000172. 6 GWM